We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATHE
9351
Alterity Therapeutics
ATHE
$80.1M
$4 ﹤0.01%
2
PSQH icon
9352
PSQ Holdings
PSQH
$13.9M
-64
Closed -$3.76K
MRNOW
9353
Murano Global Investments PLC Warrants
MRNOW
$103K
$4 ﹤0.01%
+26
New +$4
SEPAW
9354
DELISTED
SEP Acquisition Corp Warrants
SEPAW
$4 ﹤0.01%
+565
New +$78
AP.WS
9355
DELISTED
Ampco-Pittsburgh Corp Series A Warrants
AP.WS
$3 ﹤0.01%
53
-71
-57% -$6
AREN icon
9356
Arena Group
AREN
$57.1M
$3 ﹤0.01%
4
-4,094
-100% -$3.31K
ARMP icon
9357
Armata Pharmaceuticals
ARMP
$167M
$3 ﹤0.01%
1
-766
-100% -$2.19K
BFLY.WS
9358
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$3 ﹤0.01%
112
-4,769
-98% -$150
CLEU
9359
DELISTED
China Liberal Education Holdings
CLEU
-2
Closed -$3.58K
ECDAW
9360
DELISTED
ECD Automotive Design Warrant
ECDAW
$3 ﹤0.01%
135
+49
+57% +$1
ICAD
9361
DELISTED
iCAD Inc
ICAD
$3 ﹤0.01%
+2
New +$3
SABSW icon
9362
SAB Biotherapeutics Warrant
SABSW
$186K
$3 ﹤0.01%
+56
New +$2
BNAIW
9363
Brand Engagement Network Warrant
BNAIW
$3 ﹤0.01%
85
-1,737
-95% -$158
SDSTW
9364
Stardust Power Inc Warrant
SDSTW
$4.31M
$3 ﹤0.01%
+19
New +$2
GDSTR
9365
DELISTED
Goldenstone Acquisition Limited Rights
GDSTR
$3 ﹤0.01%
15
EVTL.WS
9366
DELISTED
Vertical Aerospace Ltd. Warrants, each whole warrant exercisable for 1/10th of an ordinary share at an exercise price of $115.00 per share
EVTL.WS
$3 ﹤0.01%
+99
New +$6
CELUW
9367
DELISTED
Celularity Inc
CELUW
$2 ﹤0.01%
+100
New +$3
CLDI icon
9368
Calidi Biotherapeutics
CLDI
$1.98M
0
COCHW icon
9369
Envoy Medical Warrant
COCHW
$425K
$2 ﹤0.01%
46
-2,130
-98% -$233
GWAV icon
9370
Greenwave Technology Solutions
GWAV
$2.84M
0
LGVN
9371
Longeveron
LGVN
$22.2M
$2 ﹤0.01%
1
-11
-92% -$19
MDAI icon
9372
Spectral AI
MDAI
$49.3M
$2 ﹤0.01%
1
-533
-100% -$959
NEON icon
9373
Neonode
NEON
$14.1M
$2 ﹤0.01%
1
-9,160
-100% -$19.6K
SES.WS icon
9374
SES AI Corp Warrants
SES.WS
$3.14M
$2 ﹤0.01%
36
XOSWW
9375
Xos Inc Warrants
XOSWW
$17K
$2 ﹤0.01%
99
-350
-78% -$12

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.